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We provide evidence for a prodegenerative, glial-
derived signaling framework in the Drosophila
neuromuscular system that includes caspase and
mitochondria-dependent signaling. We demonstrate
thatDrosophila TNF-a (eiger) is expressed in a subset
of peripheral glia, and the TNF-a receptor (TNFR),
Wengen, is expressed inmotoneurons. NMJdegener-
ation caused by disruption of the spectrin/ankyrin
skeleton is suppressed by an eiger mutation or by
eiger knockdown within a subset of peripheral glia.
Loss of wengen in motoneurons causes a similar
suppression providing evidence for glial-derived pro-
degenerative TNF-a signaling. Neither JNK nor NFkb
is required for prodegenerative signaling. However,
we provide evidence for the involvement of both an
initiator and effector caspase, Dronc and Dcp-1, and
mitochondrial-dependent signaling. Mutations that
deplete the axon and nerve terminal of mitochondria
suppress degeneration as domutations inDrosophila
Bcl-2 (debcl), a mitochondria-associated protein, and
Apaf-1 (dark), which linksmitochondrial signalingwith
caspase activity in other systems.
INTRODUCTION
The degeneration of neuronal processes including axons,
dendrites, and synaptic connections occurs during normal
neuronal development and in response to neuronal injury, stress,
and disease. Recent evidence in both insect dendrites (Schoen-
mann et al., 2010) andmammalian neurons (Nikolaev et al., 2009)
provides evidence for activation of effector caspases that can
drive the destruction of neuronal processes (Nikolaev et al.,
2009). An important consideration is the potential role for glia
in the degenerative mechanism. Glia have been shown to engulf
remnants of axons, dendrites, and nerve terminals following
developmental pruning (Awasaki et al., 2006). However, it
remains less clear whether glia actively participate in the degen-
erative signaling events that initiate and execute the pruning or
degenerative process as opposed to simply cleaning up the
aftermath. For example, a current hypothesis holds that degen-760 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.eration during amyotrophic lateral sclerosis (ALS) may be initi-
ated by stresses within the motoneuron and that disease
progression includes a role for surrounding cell types including
microglia and astrocytes (Barbeito et al., 2004; Henkel et al.,
2009). However, most of the evidence supporting a role for glia
in the cause or progression of ALS and motoneuron degenera-
tion is derived from analyses at the level of the spinal cord.
Very little is known about the role of peripheral glia contacting
axons or the nerve terminal. In mammals, the proinflammatory
cytokine TNF-a is expressed in Schwann cells and has been
implicated in the mechanisms of demyelination during multiple
sclerosis (Qin et al., 2008). However, the involvement of TNF-a
in ALS remains controversial. TNF-a knockout mice are viable,
and elimination of TNF-a did not protect motoneurons from
degeneration following overexpression of mutant SOD1 in
mouse motoneurons (Gowing et al., 2006). It is worth noting
that a compensatory upregulation of related proinflammatory
cytokines, IL-1-b and TLR-2, was observed, and this could
reasonably account for the failure of the TNF-a knockout to
protect against SOD1 mediated motoneuron degeneration
(Gowing et al., 2006).
We previously established a system to study motoneuron
degeneration in Drosophila. In Drosophila, genetic lesions in
the dynein dynactin complex (Eaton et al., 2002) and the spec-
trin/ankyrin skeleton (Pielage et al., 2005, 2008, 2011; Massaro
et al., 2009) disrupt axonal transport and cause degeneration
of the neuromuscular junction (NMJ) and motor axons. Moto-
neuron degeneration in Drosophila shares many of the cellular
hallmarks of degeneration in mammalian neurons, observed at
the light level, ultrastructurally and electrophysiologically.
Genetic lesions in dynactin and the spectrin/ankyrin skeleton
cause ALS and spinal cerebellar ataxia type 5 (SCA5) in humans
(Puls et al., 2003; Ikeda et al., 2006). Mouse and Drosophila
models of these diseases employing similar genetic lesions
have been developed (LaMonte et al., 2002; Lorenzo et al.,
2010). Taken together, these data imply that common cellular
stresses are able to initiate motoneuron degeneration in insects
and mammals. Furthermore, motoneuron degeneration in Dro-
sophila can be suppressed by expression of awallerian degener-
ation slow (WldS) transgene, implying the existence of common
degenerative signaling pathways in mammalian and fly neuro-
muscular systems (Massaro et al., 2009).
Taking advantage of an in vivo model system for motoneuron
degeneration in Drosophila, we now provide evidence for a
prodegenerative-signaling pathway that originates within the
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close proximity to the motoneuron axon. We present evidence
that TNF-a, expressed in a subset of peripheral glia, acts via
a conserved TNF-a receptor (TNFR), expressed in motoneurons,
to initiate prodegenerative signaling within the motor axon. The
prodegenerative-signaling pathway is genetically independent
of c-Jun N-terminal kinase (JNK) and NFkb, two prominent path-
ways that reside downstreamof the TNFR. Instead, we show that
the prodegenerative process requires the Drosophila effector
caspase, Dcp-1, which we demonstrate is both necessary and
sufficient for motoneuron degeneration. Finally, we provide
evidence for mitochondrial-dependent signaling in the degener-
ative response.
RESULTS
The development of a system to study degeneration in
Drosophila motoneurons has allowed us to assay for mutations
that are necessary for prodegenerative-signaling pathways
(Eaton et al., 2002; Massaro et al., 2009; Pielage et al., 2011).
We predict that loss of genes necessary for prodegenerative
signaling will prevent or impair the initiation and progression of
degeneration that normally occurs in animals with aberrant spec-
trin or ankyrin2 (ank2) genes. Importantly, our search for prode-
generative-signaling molecules is being performed in vivo, with
an intact neuromuscular system includingmotoneurons,muscle,
and surrounding glia.
In a candidate-based screen for prodegenerative-signaling
molecules, we identified a transposon insertion in theDrosophila
homolog of TNF-a known as eiger. The eiger loss-of-function
mutants have no noticeable morphological or cell death defects
(Igaki et al., 2002). The transposon insertion that we identified is
inserted 21 bp upstream of the transcriptional start site and
contains a GAL4 element allowing us to define the expression
pattern of the eiger gene within the neuromuscular system
(Figure 1A).
We first drove expression of UAS-GFP harboring a nuclear
localization sequence using the eiger-GAL4 element. We find
that eiger-GAL4 is expressed in a subset of glia, as identified by
costaining with a pan-glial antibody (Figure 1B; also see
Figure S1 available online) (anti-REPO, Reversed Polarity). Each
Drosophila peripheral nerve contains inner glial cells that wrap
the motor and sensory axons, an outer mesodermally derived
perineural glial layer that does not form direct contact with axons,
and third glial population termed subperineural glia that form
short processes toward the axon fascicle (Stork et al., 2008). To
define which subpopulation of glia expresses Eiger, we drove
membrane-tethered GFP (UAS-CD8-GFP) using eiger-GAL4.
We find that CD8-GFP expression surrounds the motor axons,
colabeled with a marker of neuronal membranes (anti-HRP).
Indeed, membrane-tethered GFP is observed to extend all the
way to the site where the motor axon makes contact with muscle
at the NMJ (Figure 1C). The particular site imaged at muscle 4
contains one or two motor axons surrounded by glia (Figure 1C).
Consistent with recently reported data, CD8-GFP expressed in
these glia rarely extends to overlap synaptic boutons within the
NMJ, indicating that the glial process stops at the site of moto-
neuron/muscle contact (Fuentes-Medel et al., 2009). These dataindicate that eiger is selectively expressed in a subset of periph-
eral glia that surround motoneuron axons including the region of
motor axons just prior to the point of nerve-muscle contact.
Importantly, this is true for all peripheral NMJs that we visualized.
To investigate whether eiger expressing peripheral glia might
be in direct contact with motor axons, we examined tangential
sections of the NMJ using thin-section transmission electron
microscopy (EM) (Figure 1D). We find evidence of septate junc-
tions that are diagnostic for the interface between axons and glial
cells (Banerjee and Bhat, 2008). Consistent with our light-level
observations, we find evidence that peripheral glia extend all
the way to the site of nerve muscle contact but do not invade
the muscle cell. Instead, the glial cell ends in a foot-like structure
that does not appear to include any adhesion between the glial
cell and muscle membranes (Figure 1D). Thus, glia are in direct
contact with the motor axon just prior to muscle invasion, and
these glia are likely to be the Eiger expressing glia that we
observe at the light level.
Finally, we took advantage of a previously generated anti-
Eiger antibody (Igaki et al., 2009).We find that Eiger protein is en-
riched in peripheral nerves and that this staining is strongly
diminished in a newly generated eigermutation that is predicted
to be a molecular null (eigerD25; see next section) (Figures
1E–1G). Note that the images of anti-Eiger staining in peripheral
nerves are projection images from confocal image stacks. Thus,
the puncta of anti-Eiger that overlap neuronal anti-HRP include
staining above and below the nerve bundle. We rarely observe
staining within the HRP-positive nerve bundle when examining
individual optical sections (data not shown). Finally, we do not
observe significant Eiger staining at the NMJ, suggesting that
Eiger is a glia-derived protein with a distribution that is restricted
to the domain defined by the glial ensheathment of peripheral
nerves.
To establish that anti-Eiger staining is derived from glia, we
used a previously characterizedUAS-eiger-RNAi transgene (Igaki
et al., 2002) to knock down eiger expression with a neuron-
specific GAL4 (C155-GAL4), a pan-glial GAL4 (repo-GAL4), or
our newly identified eiger-GAL4 driver. Pan neuronal knockdown
has no quantitative effect on the levels of Eiger staining in periph-
eral nerves (Figure 1G). However, both repo-GAL4 and eiger-
GAL4 significantly decrease Eiger staining in peripheral nerves
to levels that are not statistically significantly different from that
observed in the eiger mutation (see Figure S2 for additional
images). These data are consistent with the conclusion that Eiger
protein is derived from a subset of peripheral glia in which the
eiger gene appears to be expressed (Figure 1).
Loss of Eiger Suppresses Neuromuscular Degeneration
We have developed a quantitative assay for neuromuscular
degeneration at the Drosophila NMJ (Eaton et al., 2002; Eaton
and Davis, 2005; Pielage et al., 2005, 2011; Massaro et al.,
2009). In brief we visualize the motoneuron membrane (anti-
HRP), presynaptic active zones (anti-Brp), and postsynaptic
muscle folds at the NMJ (anti-Dlg). In wild-type animals there
is perfect apposition of the pre- and postsynaptic markers
throughout the NMJ. However, following a variety of stresses
associated with the cause of neuromuscular degeneration in
mammalian systems including disrupted axonal transportNeuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc. 761
Figure 1. Eiger Is Present in a Subset of Peripheral Glia that Reside in Close Proximity to Motoneurons
(A) Schematic of the eiger locus. The egr-GAL4 insertion resides 21 bp upstream of the egr transcriptional start site.
(B) Motoneurons expressing nuclear-GFP (green, shown in isolation at left) driven in a subset of peripheral glia by egr-GAL4 and stained with Repo (red) to
visualize all glia nuclei and HRP (blue) to visualize neuronal membranes.
(C) Expression of membrane-tethered GFP (CD8-GFP) driven by egr-GAL4 and visualized at the muscle 4 NMJ (shown in isolation at left, green in merged image
at right). The presynaptic motoneuron membrane is stained with HRP (blue), and the postsynaptic SSR marker Dlg (red) delineates postsynaptic densities.
(D) Electronmicrograph of an individual motoneuron axon, ensheathed by glia (pseudo-colored yellow), extending toward and contactingmuscle 12 with a terminal
NMJsurroundedbypostsynaptic SSR. Insets (1–3) showmagnifiedboxed regions as indicated. Inset 1 showsan active zonewith accumulationof synaptic vesicles,
inset 2 shows glial extension and contact with the muscle, and inset 3 shows characteristic septate junctions between glia and neurons. Scale bar, 500 nm.
(E) A projection image from confocal image stacks of an individual wild-type larval nerve. Eiger protein (green) localizes to glia that surround and ensheath the
neurons (red).
(F) Two larval nerves from the egrD25 mutant stained with the neuronal membrane marker HRP (red) showing loss of Eiger staining (green).
(G) Levels of Eiger immunoreactivity are quantified in nerves. wt = w1118 (ten animals); egr = eigerD25/eiger D25 (ten animals); C155; egr-IR = elavC155-GAL4; pUAS-
egrRNAi (four animals); egrG4; egr-IR = egr-GAL4; pUAS-egrRNAi (five animals); repoG4; egr-IR = Repo-GAL4; pUAS-egrRNAi (five animals). Error bars
represent SEM. p values were determined using one-way ANOVA with post hoc Tukey-Kramer: **p < 0.01; ***p < 0.001. Statistical differences remain when
comparisons are made using Student’s t test. n.s., not significant.
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2005), or disruption of the spectrin/ankyrin skeleton (Pielage
et al., 2005, 2011), the presynaptic terminal degenerates. The
phenotype of motoneuron degeneration includes fragmentation
of the presynaptic motoneuron membrane so that it is no longer
continuous with the axon, altered organization of cell surface
antigens including cell adhesion molecules (Pielage et al.,
2005), ultrastructural evidence of degeneration based on serial
EM sectioning of degenerating NMJs (Eaton et al., 2002), elimi-
nation of presynaptic antigens including anti-Brp, and morpho-
logically disrupted mitochondria (Pielage et al., 2011). We find
that loss of presynaptic antigens precedes the disassembly of
the postsynaptic muscle membrane folds termed the subsynap-
tic reticulum (SSR). Therefore, we can quantify sites where well-
organized postsynaptic SSR is no longer opposed by the762 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.presynaptic motoneuron. We have previously demonstrated
that this assay reports the degeneration of the presynaptic
terminal (Eaton et al., 2002; Eaton and Davis, 2005; Pielage
et al., 2005, 2011; Massaro et al., 2009), and that this degenera-
tion is progressive during larval development (Massaro et al.,
2009). This phenotype cannot be accounted for by altered
synapse development or sprouting of the presynaptic nerve
terminal (Eaton et al., 2002; Eaton and Davis, 2005; Pielage
et al., 2005; Massaro et al., 2009).
To test a potential role for Eiger in neuromuscular degeneration,
we generated a small deletion in the eiger gene by imprecise exci-
sion of the eiger-GAL4 transposon insertion, which resides 21 bp
upstream of the 50 transcriptional start site (Figure 1A). The result-
ing small deletion termed eigerD25 removes approximately 1.5 kb
of genomicDNAwithin the eiger locus, starting from the site of the
Figure 2. eiger Suppresses ank2-Dependent Degeneration at the NMJ
(A–D) Representative images of third-instar muscle 6/7 NMJs stained with the presynaptic active zone marker Brp (green, middle panels) and the postsynaptic
marker Dlg (red, right panels). (A) A wild-type NMJ showing presynaptic Brp (green, middle panel) in perfect apposition with postsynaptic Dlg (red, right panel). (B)
eiger null mutations do not affect NMJmorphology or colocalization of Brp (green,middle panel) and Dlg (red, right panel) at muscle 6/7. (C) NMJ of a homozygous
ank2 animal showing organized postsynaptic Dlg (red, right panel) with very little opposing presynaptic Brp staining, indicating that the presynaptic nerve terminal
has been eliminated. (D) Animals that are homozygous for both eiger and ank2 have a remarkably improved NMJ despite the presence of the ank2 mutation.
Presynaptic Brp (green, middle panel) now colocalizes with postsynaptic Dlg (red, right panel) staining. Scale bar, 10 mm.
(E and F) Quantification of degeneration severity (E) is measured as the average number of boutons retracted per individual NMJ, and cumulative percentage of
degeneration severity (F) is plotted as cumulative frequency histogram for each genotype. wt = w1118 (n = 129 NMJs); egr = egrD25/egrD25 (n = 75 NMJs); ank2 =
ank22001/ank22001 (n = 141 NMJs); egr; ank2 = egrD25/egrD25; ank22001/ank22001 (n = 129 NMJs); egrG4/egr-IR; ank = egr-GAL4/pUAS-egr-RNAi; ank/ank (n = 90).
Error bars represent SEM. p values were determined using one-way ANOVA with post hoc Tukey-Kramer: ***p < 0.001. Statistical differences remain when
comparisons are made using Student’s t test. n.s., not significant.
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and translational start sites as well as the entire first coding
exon (Figure 1A). Therefore, the eigerD25 mutation is predicted
to be a null mutation. Examining the NMJ of eiger null mutants
demonstrates normal NMJ morphology and wild-type apposition
of pre- and postsynaptic markers (Figure 2). Thus, eiger is not
required for normal NMJ growth or stability.
We next asked whether loss of eiger could suppress NMJ
degeneration in the ank2mutant background. As reported previ-
ously, mutations in ank2 cause severe NMJ degeneration leading
to complete elimination of the presynaptic nerve terminal at many
NMJs (Figures 2C, 2E, and 2F). However, whenwe examine eiger;ank2 double mutant animals, we find that the severity of
NMJ degeneration is significantly suppressed (Figures 2D–2F;
p < 0.001). To examine the tissue specificity of this effect, we
knocked down Eiger in eiger-expressing glia using the eiger-
GAL4 driver and demonstrate that glial-specific Eiger knockdown
suppresses NMJ degeneration as efficiently as the eiger null
mutation (Figures 2E and 2F; p < 0.001). These data indicate
that a subset of peripheral glia is the source of Eiger that is neces-
sary for prodegenerative signaling. The suppression of NMJ
degeneration is not a secondary consequence of enhanced
growth because eigermutants do not have a significantly different
number of boutons compared to wild-type animals (Figure S3).Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc. 763
Figure 3. eiger Suppresses ank2-Dependent Degeneration Despite
Persistent Cellular Stresses
(A–D) Representative images of individual third-instar nerve bundles stained for
the neuronal membrane marker HRP (red) and the active zone marker Brp
(green), which accumulates in ank2mutant axons. All images were taken at the
same time with the same exposure conditions. (A) Wild-type nerve bundle with
no visible Brp accumulations. (B) egr mutant nerve bundle that looks similar to
wild-type with no visible Brp accumulations. (C) ank2 nerve bundle showing
significant amounts of Brp accumulations. (D) Nerve bundle from a double
homozygous mutant for both egr and ank2, showing significant axonal Brp
accumulations. Total Brp fluorescence intensity integrated over total nerve area
is the following: wt = w1118 (n = 17 nerve bundles; average 8.16 arbitrary units);
egr = egrD25/egrD25 (n = 17 nerve bundles; average 10.54 arbitrary units); ank2 =
ank22001/ank22001 (n = 21 nerve bundles; average 30.6 arbitrary units); egr;
ank2 = egrD25/egrD25; ank22001/ank22001 (n = 17 nerve bundles; average 31.6
arbitrary units). ank2 and egr; ank2 both have significantly more Brp total fluo-
rescence than either wild-type or egr mutants alone (p < 0.001). The p values
were determined using one-way ANOVA with post hoc Tukey-Kramer. Statis-
tical differences remain when comparisons are made using Student’s t test.
(E–H) Representative images of third-instar muscle 6/7 NMJs stained for the
neuronal microtubule-associated protein Futsch (green), the presynaptic
membrane marker HRP (blue), and the postsynaptic marker Dlg (red). Insets
show Futsch staining only. (E) A wild-type NMJ shows an elongated and
organized Futsch-positive microtubule cytoskeleton. (F) An NMJ lacking Eiger
protein (egrD25) also shows an elongated and organized Futsch-positive
microtubule cytoskeleton. (G) An NMJ mutant for ank2 shows disorganized
Futsch stainingwith accumulations within boutons. (H) Animals that aremutant
for both egr and ank2 do not restore microtubule organization.
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with neurodegeneration. The loss of ank2 causes axonal block-
ages, consistent with severely disrupted axonal transport that
is often associated with neuromuscular degeneration in this
and other systems (LaMonte et al., 2002). Loss of ank2 also
causes a severe disruption of the axonal and synaptic microtu-
bule cytoskeleton, a common stress that can lead to neuromus-
cular degeneration (Bettencourt da Cruz et al., 2005). We find
that both of these disease-related phenotypes are just as
severe when comparing ank2with the eiger; ank2 double mutant
(Figure 3). These analyses include qualitative analysis of Futsch
organization within the nerve terminal (Figures 3E–3H) and quan-
titative analysis of Brp staining within the peripheral nerves
(Figures 3A–3D). Total Brp fluorescence intensity integrated
over total nerve area is as follows: wt = 8.1 ± 1.0 (arbitrary
fluorescence units, n = 17 nerve bundles); eiger = 10.5 ± 1.3
(n = 17; not significant compared to wt); ank2 = 31.7 ± 4.5
(n = 17; p < 0.001 compared to wild-type); and eiger; ank2 =
30.5 ± 2.9 (n = 21; p < 0.001 compared to wt and not significantly
different than ank2 alone). These data indicate that loss of Eiger
does not improve neuronal health by acting directly to improve
axonal transport or cytoskeletal organization. These data are
also consistent with the recent demonstration thatWldS expres-
sion can suppress NMJ degeneration in our system without
affecting the presence of axonal blockages or cytoskeletal orga-
nization (Massaro et al., 2009). Together, our data demonstrate
that loss of Eiger can suppress neuromuscular degeneration
following a severe cytological stress to the motoneuron.
Finally, we overexpressed Eiger in peripheral glia using the
eiger-GAL4 driver. We find no evidence of NMJ degeneration
or impaired animal health (data not shown). One possibility is
that Eiger overexpression is not sufficient to activate the down-
stream TNFR. Eiger is a type II transmembrane protein that,
like TNF-a, must be cleaved in order to be secreted. In verte-
brates this is achieved by TNF-a converting enzyme (TACE),
and a TACE homolog is present in Drosophila, though no muta-
tions in this gene currently exist.
The TNFR Wengen Functions in Motoneurons to
Promote Neuromuscular Degeneration
To date, Wengen is the only known TNFR in Drosophila (Kanda
et al., 2002; Kauppila et al., 2003). wengen mRNA is expressed
at all stages of development, much like its ligand eiger (Kanda
et al., 2002), and both wengen and eiger are expressed within
the ventral nerve cord at late embryonic stages (Kauppila et al.,
2003) . It has been shown that Eiger and Wengen can interact
physically with each other through their TNF homology and
TNFR homology domains, respectively. This evolutionarily
conserved TNF-a-like signaling pathway has now been shown
to be involved in JNK-induced cell death in the fly eye (Kanda
et al., 2002; Kauppila et al., 2003; Babcock et al., 2009).
We have determined that Wengen is expressed in motoneu-
rons, where it could function as a receptor for glial-derived
Eiger signaling. Expression of Wengen cDNA was determined
by RT-PCR analysis from RNA made specifically from a FACS-
sorted population of GFP-positive motoneurons isolated from
third-instar larval brain (Figure S4). Because Wengen is a type I
membrane protein, we tagged the C-terminal tail with a Venus764 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.tag to visualizeWengen localization (Kanda et al., 2002; Kauppila
et al., 2003). When expressed in motoneurons using OK371-
GAL4, Wengen-Venus accumulates along motor axons within
peripheral nerves (Figure 4A). Wengen-Venus also traffics to
the presynaptic nerve terminal at the NMJ, where it is distributed
in a punctate manner throughout synaptic boutons and inter-
bouton regions (Figure 4B). It is worth noting that expression in
axons is considerably stronger than within the NMJ, even
when one assesses staining in isolated axons just prior tomuscle
Figure 4. Presynaptic Knockdown of Wengen Suppresses ank2-Dependent Degeneration
(A) Wengen-Venus (green) expressed in motor neurons using OK371-GAL4 shows localization to motoneuron axons that are costained with the neuronal
membrane marker HRP (red).
(B) Wengen-Venus (green) driven by OK371-GAL4. Wengen-Venus localizes to the NMJ, albeit at lower levels than in the axons.
(C) Neuronal-specific Wengen knockdown stained with the presynaptic active zone marker Brp (green) and the postsynaptic marker Dlg (red) at NMJ 6/7.
Presynaptic expression of wengen-RNAi does not cause any significant synaptic degeneration.
(D) Representative image stained with Brp (green) and Dlg (red) showing suppression of ank2-dependent degeneration by neuronal expression ofwengen-RNAi.
(E and F) Quantification of degeneration severity as in Figures 2E and 2F. wt = w1118 (n = 59 NMJs); wgnRNAi = elavC155-GAL4/+; wgnRNAi/+; ank22001/+ (n = 58
NMJs); ank2 = ank22001/ank22001 (n = 52 NMJs); wgnRNAi; ank2 = elavC155-GAL4/+; wgnRNAi/+; ank22001/ank22001 (n = 159 NMJs). ank2 mutants have
significantly more synaptic degeneration than either wild-type or wengen-RNAi larva (p < 0.001), whereas wgn-RNAi; ank2 larva have significant suppression of
ank2-dependent degeneration (p < 0.001). Error bars represent SEM. p values were determined using one-way ANOVA with post hoc Tukey-Kramer: *p < 0.05;
***p < 0.001. Statistical differences remain when comparisons are made using Student’s t test. n.s., not significant.
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occur in axons where it is in a position to receive signaling from
glial-derived Eiger. Finally, as a control, we determined that the
axonal staining does not colocalize with other synaptic protein
markers, so the accumulation of Wengen-Venus in axons cannot
be attributed to impaired axonal transport (Figure S5).
In order to examine whetherWengen plays a role in neuromus-
cular degeneration, we used a previously established and veri-
fied wengen RNAi (wgnRNAi) construct (Kanda et al., 2002;
Kauppila et al., 2003; Babcock et al., 2009; Xue et al., 2007; Igaki
et al., 2002) in an attempt to suppress the degeneration pheno-
type observed in ank2 mutants. Animals with knockdown of
wengen in motoneurons show no evidence of NMJ degeneration
(Figures 4C, 4E, and 4F). However, neuronal expression ofwgnRNAi in an ank2 background significantly suppresses the
severity of synaptic degeneration when compared with ank2
animals alone (Figures 4D–4F). Again, this suppression of neuro-
muscular degeneration cannot be accounted for by enhanced
synaptic growth because bouton numbers are normal when
wgnRNAi is neuronally expressed in an otherwise wild-type
background (Figure S3). Again, we controlled for the presence
of axonal blockages and defects in synaptic microtubules
following wgnRNAi in the ank2 mutant background. There is no
suppression of axonal blockages nor is there an improvement
in the organization of the microtubule cytoskeleton (Figure S6).
Thus, Wengen is expressed in motoneurons, traffics to the
axon and presynaptic nerve terminal, and is necessary, in moto-
neurons, for efficient neuromuscular degeneration followingNeuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc. 765
Figure 5. Synaptic Transmission Deficiencies in
ank2 Mutants Are Suppressed by Both eiger
Mutations and wengen-RNAi
(A) Average mEPSP amplitude for wild-type, egr, ank2,
and the double mutant egr; ank2. In (A)–(D), values are
averages from individual recordings, and genotypic
averages are shown as large horizontal bars with SEM
indicated by the position of smaller horizontal bars above
and below the mean. wt = w1118 (average mEPSP,
1.23mV, n = 26); egr = eigerD25/eiger D25 (averagemEPSP,
1.2 mV, n = 24); ank2 = ank22001/ank22001 (average
mEPSP, 0.98 mV, n = 40); egr; ank2 = eiger D25/eiger D25;
ank22001/ank22001 (average mEPSP, 1.13 mV, n = 28).
There is no significant difference between genotypes.
(B) The ank2 mutants have a large number of recordings
with average EPSPs below 25 mV, the limit of the wild-
type distribution (red dash line). wt = w1118 (average EPSP,
44.2 mV, n = 26); egr = egrD25/egrD25 (average
EPSP, 42.8mV, n = 24); ank2 = ank22001/ank22001 (average
EPSP, 29.5mV, n = 40); egr; ank2 = egrD25/egrD25;
ank22001/ank22001 (average EPSP, 35.9 mV, n = 28). A
significant increase in EPSP amplitude is observed
comparing ank2with egr; ank2 (*p = 0.02, Student’s t test).
(C) Average mEPSP amplitude for wild-type, wgn-RNAi,
ank2, and wgn-RNAi; ank2 larva. wt = w1118 (average
mEPSP, 1.23mV, n = 26);wgnRNAi = elavC155-GAL4;wgn-
RNAi (average mEPSP, 1.41 mV, n = 16); ank2 = ank22001/
ank22001 (average mEPSP, 0.98 mV, n = 40); wgnRNAi;
ank2 = elavC155-GAL4; wgn-RNAi/+; ank2/ank2 (average
mEPSP, 0.96mV, n = 30). There is no difference comparing
ank2 with wgn-RNAi/+; ank2/ank2. n.s., not significant.
(D) Average EPSP amplitude for wild-type, wgn-RNAi,
ank2, andwgn-RNAi; ank2 larva. wt =w1118 (averageEPSP,
44.2 mV, n = 26); wgnRNAi = elavC155-GAL4; wgn-RNAi
(average EPSP, 48.08 mV, n = 16); ank2 = ank22001/
ank22001 (averageEPSP, 29.5mV, n = 40);wgnRNAi; ank2=
elavC155-GAL4; wgn-RNAi/+; ank2/ank2 (average EPSP,
32.8 mV, n = 30). There is a significant increase in average
EPSP amplitude comparing ank2 and wgnRNAi; ank2
(*p = 0.05, Student’s t test).
(E) Representative EPSP and mEPSP traces for wild-type,
eiger, ank2, and egr; ank2.
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a receptor for glial-derived Eiger in a prodegenerative-signaling
pathway. Finally, we find that Wengen overexpression is not
sufficient to cause NMJ degeneration and does not alter animal
health (data not shown). These data indicate that receptor over-
expression is not sufficient to activate this signaling pathway
in vivo.
Loss of Eiger or Wengen in the ank2Mutant Background
Improves Neuromuscular Function
We first demonstrate that eiger mutants have average EPSP
amplitudes that are statistically similar to wild-type (Figure 5B).
Next, we confirmed that the loss of ank2 results in impaired
average EPSP amplitudes (average EPSP = 29.5mV; Figure 5B).
The occurrence of severely degenerated NMJs in ank2 mutants
(Figures 2E and 2F) correlates well with the number of recordings
that show largedefects in EPSPamplitude compared towild-type
(Figure 5; Pielage et al., 2005). Next, we demonstrate that animals
homozygous for both eiger and ank2 exhibit a significant recovery
in synaptic neurotransmission (from 29.5mV in ank2 mutants to766 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.35.9 mV in eiger; ank2 double mutants) and a near complete
rescue in the number of small EPSPs (below 25 mV; Figure 5B).
There is no consistent change in mEPSP amplitude that could
account for these changes in EPSP amplitude (Figure 5A).
Together, these results demonstrate that loss of Eiger can signif-
icantly improve the physiological function of the ank2 mutant
NMJs, consistent with a functional improvement at the NMJ
that parallels suppression of anatomical degeneration.
It should be noted that average EPSP amplitude is not
completely restored to wild-type values despite the general
improvement of synaptic function described above. This is likely
because we have not rescued all aspects of neuronal health. As
show in Figure 3, there remain defects in axonal transport and
microtubule organization that could reasonably impair synaptic
transmission. Thus, although we have restored anatomical and
functional stability, we have not completely restored neuronal
health.
Finally, we also recorded from ank2 mutants in which
wgnRNAi is expressed presynaptically (Figure 5). In this case
there is improved synaptic transmission that is similar to that
Neuron
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These data demonstrate that the loss of wengen in neurons
causes a functional improvement at the NMJ of the ank2mutant,
consistent with what is observed in the eiger; ank2 double
mutant.
The Effector Caspase Dcp-1 Is Necessary and Sufficient
for Neuromuscular Degeneration without Cell Death in
the ank2 Mutant
Previously, it was proposed that Wengen does not possess
a Death Domain that is generally thought to be necessary for
activation of caspase signaling (Kanda et al., 2002). We now
provide evidence for the existence of a Death Domain inWengen
based on a more extensive sequence analysis comparing resi-
dues critical for caspase-mediated signaling (McDonald et al.,
2001; Figure S7). This analysis supports the possibility that
Wengen could signal directly to axonal and synaptic caspases.
There are seven caspases encoded in the Drosophila genome
including the initiator caspases Dredd, Nc (Dronc), and Strica,
and the effector caspases Drice, Dcp-1, Decay, and Damm. Of
the effector caspases only Drice and Dcp-1 have been shown
to be enriched in the larval nervous system, whereas Dronc
and Dredd are initiator caspases with enriched expression in
the larval CNS (Chintapalli et al., 2007). We first tested whether
caspase overexpression might cause motoneuron degenera-
tion. Overexpression of the initiator caspase Dredd in motoneu-
rons was without effect. However, overexpression of Dronc
in motoneurons caused embryonic lethality, suggesting that
Dronc might be an initiator caspase in motoneurons. We then
decreasedGAL4-dependentUAS-Dronc expression by lowering
the temperature at which we raised the animals to 18C. Under
this condition, rare larvae survive to late larval stages (Figure 6F).
These animals show severe NMJ degeneration with many
complete NMJ eliminations. These data demonstrate that Dronc
expression is sufficient to cause NMJ degeneration. Consistent
with this finding, we demonstrate that Flag-tagged Dronc
(Yang et al., 2010) traffics to the axon and presynaptic nerve
terminal (Figure 7A).
We next overexpressed effector caspases. Drice was without
effect. By contrast, overexpression of UAS-Dcp-1 in motoneu-
rons caused severe motoneuron degeneration (Figure 6). We
confirmed the severity of anatomical NMJ degeneration by
recording from these NMJs. We demonstrate that synaptic
transmission is severely disrupted (Figure S8). Next, we coex-
pressed UAS-Dcp-1 and UAS-CD8-GFP in a small subset of
motor axons using the Eve-GAL4 driver so that we could visu-
alize individual axons in the peripheral motor nerve. We label
between one and four motor axons with UAS-CD8-GFP using
the Eve-GAL4 driver. Overexpression of UAS-CD8-GFP alone
labels individual motor axons that can be traced continuously,
without break, from the CNS to the NMJ (Figure 6C). By contrast,
when UAS-CD8-GFP is coexpressed with UAS-Dcp-1, we find
clear evidence that axons have a narrower caliber and clear
evidence of axonal breaks or fragmentation (Figure 6D). These
data demonstrate that expression of UAS-Dcp-1 causes axonal
degeneration as well as degeneration at the nerve terminal. As
a control, we demonstrate that the glial expression of UAS-
Dcp-1 is without effect (Figure 6E). As with the initiator caspaseDronc, Venus-tagged Dcp-1 traffics to the axon and presynaptic
nerve terminal (Figure 7B).
The observation that overexpression of UAS-Dcp-1 is able to
initiate caspase activity suggests that this caspase can be
autoactivated through overexpression because it seems unlikely
that there is a constitutively active initiator caspase activity in
motoneurons. This is consistent with prior demonstration that
caspase 6, unlike caspase 3 and 7, can undergo autoactivation
(Klaiman et al., 2009; Wang et al., 2010). At present, we cannot
rule out the possibility that Drice is ineffective at causing NMJ
degeneration because it requires initiator caspase activity in
motoneurons.
There are two additional features of this experiment that are
interesting. First, axonal degeneration following expression of
UAS-Dcp-1 does not spread to adjacent axons in this system.
When UAS-Dcp-1 is expressed by Eve-GAL4, only one of two
motor axons is labeled that innervatemuscle 1.We find evidence
of degeneration at the motoneuron expressing UAS-Dcp-1, but
not in the adjacent axon innervating the same muscle target
(there is also no evidence of compensatory growth of the remain-
ing terminal) (data not shown). Second, we find no evidence of
neuronal sprouting at sites of broken axons. We presume that
this is due to the fact that these axons are undergoing active
degeneration and are not responding to injury or physical
breakage, which can lead to sprouting (Ayaz et al., 2008). Finally,
degeneration following expression of UAS-Dcp-1 does not
include motoneuron cell death. We assayed cell death using a
TUNEL assay and found no evidence of motoneuron cell
death (data not shown), consistent with prior evidence of NMJ
degeneration without cell death in the ank2 mutation (Pielage
et al., 2008), following loss of spectrin (Pielage et al., 2005) and
following disruption of axonal transport (Eaton et al., 2002).
This is also consistent with caspase 6 activation not causing
cell death in mammalian systems (Klaiman et al., 2009; Nikolaev
et al., 2009).
Because overexpression of UAS-Dcp-1 is sufficient to cause
motoneuron degeneration, we asked whether loss of Dcp-1
could suppress NMJ degeneration in the ank2 mutant back-
ground. We acquired a strong loss-of-function mutation in
Dcp-1 (Laundrie et al., 2003) and generated double mutant
combinations with ank2. We find that loss of Dcp-1 alone does
not have any significant effect on larval viability or NMJ integrity
or growth (Figure S3). Remarkably, we find that NMJ degenera-
tion is almost completely blocked in the dcp-1; ank2 double
mutant (Figures 6G and 6H; see also Figure S9 for representative
images of suppression). Even more remarkable, a heterozygous
dcp-1/+ mutation is nearly as effective at blocking neuromus-
cular degeneration (Figures 6G and 6H), indicating that the
degenerative response is strikingly sensitive to the levels of
Dcp-1. Thus, our data demonstrate that Dcp-1 is both necessary
for degeneration following a cytological stress and is sufficient to
drive neuromuscular and axonal degeneration.
Finally, because Eiger appears to be absent from the NMJ
where degeneration occurs, we asked whether the caspases
might be mobile within the neuron and thereby capable of
causing degeneration at sites distant from signal initiation. We
used Dcp-1-Venus, which will tag both active and inactive
Dcp-1 protein, and performed standard FRAP (fluorescenceNeuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc. 767
Figure 6. Dcp-1 Is Necessary and Sufficient for Prodegenerative Signaling
(A and B) Representative immunofluorescence images of NMJs at muscle 6/7 in larva expressing full-length Dcp-1 in neurons. NMJs are stained with the
presynaptic marker Brp (green), the postsynaptic marker Dlg (red), and the neuronal membrane marker HRP (blue). A range of phenotypes exists when Dcp-1 is
expressed in neurons, including significant synaptic degeneration (A) and complete presynaptic degeneration resulting in discontinuous HRP staining (B).
(C) Membrane-bound GFP expression (green) in single motoneurons being driven by the EveRRa-GAL4 driver within an otherwise wild-type nerve bundle. A
single axon is visualized.
(D) Expression of full-length Dcp-1 and membrane-bound GFP (green) in single motoneurons by the EveRRa-GAL4 driver within a nerve bundle. Expression of
Dcp-1 causes motoneurons to degenerate along their length.
(E) Quantification of degeneration frequency as measured by the average percentage of NMJs retracted per animal in wild-type, dcp-1 homozygous mutants,
ank2, and in larva expressingDcp-1 in all neurons or in a subset of peripheral glia with egr-GAL4. wt =w1118 (n = 129NMJs); dcp-1 = dcp-1Prev1/dcp-1Prev1 (n = 130
NMJs); ank2 = ank22001/ank22001 (n = 122 NMJs);C155 >UAS-Dcp1 = elavC155-GAL4;UAS-Dcp-1/+ (n = 96 NMJs); egrG4 >UAS-Dcp-1 = egr-GAL4/UAS-Dcp-1
(n = 80). Dcp-1 expression in neurons causes significantly more synaptic degeneration events that have >1 bouton, >7 boutons retracted, >20 boutons retracted,
and complete synaptic eliminations (*p < 0.05; ***p < 0.001). Expression of Dcp-1 in Eiger expressing peripheral glia causes no degeneration.
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Figure 7. Caspases Localize to Drosophila NMJ
(A) Representative image of third-instar muscle 6/7 NMJs expressing FLAG-tagged initiator caspase, Dronc, in neurons. Dronc-FLAG (green) localizes within
neurons demarcated by HRP (blue) and to boutons, Dlg (red). Dronc-FLAG, elavC155-GAL4;; pUAS-Dronc-FLAG.
(B) Representative images of third-instar 6/7 NMJs expressing Dcp-1-Venus. Dcp-1-Venus, elavC155-GAL4; pUAS-Dcp-1-Venus.
(C) Confocal image of an axonal segment of a motoneuron projecting to muscle 4 (segment A2), in which UAS-Dcp-1-Venus is expressed under the control of
elavC155. The red box marks the region that was bleached during the FRAP recording shown in (D).
(D) Normalized axonal FRAP time course. Fluorescence recovery was fitted with a double exponential function. Note that theDcp-1-Venus fluorescence after the
bleach pulse returns to 75% of baseline fluorescence levels indicating that most of the Dcp-1-Venus is mobile within the axonal cytosol.
(E) Average mobile fraction (left) and half-maximum recovery time (t1/2, right) of FRAP time courses recorded in axons expressing Dcp-1-Venus (n = 8, red), or
cytosolic GFP (OK371-GAL4; UAS-T2-GFP, n = 6, black). The averagemobile fraction ofDcp-1-Venus (0.81 ± 0.04) was slightly smaller than cytosolic GFP (0.93 ±
0.02; p = 0.03), and the average recovery of Dcp-1-Venus (t1/2 = 1.36 ± 0.24 s) was slightly slower than in cytosolic GFP (t1/2 = 0.93 ± 0.02 s; p = 0.05).
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fraction of Dcp-1-Venus is diffusible within the axon (Figures
7C–7E). This is consistent with the possibility that caspases
could cause destruction at a distance from the site of activation.
However, we acknowledge that other signaling components
could also be mobile and causal.
Evidence for Localized, Mitochondria-Dependent,
Prodegenerative Signaling
We next explored other potential components of Eiger-Wengen
prodegenerative signaling. Three prominent signaling pathways
have been defined downstream of TNFRs in other systems that
can be distinguished by the involvement of NFkb, JNK, and
caspases (Aggarwal, 2000). In theDrosophila visual system, Eiger
and Wengen have been shown to influence JNK signaling
(Kauppila et al., 2003). However, rather than suppressing degen-(F) Quantification of degeneration frequency as measured above in wild-type and
NMJs); elavC155-GAL4; UAS-Drice (n = 100 NMJs); elavC155-GAL4; UAS-Dredd (n
(n = 106 NMJs). Only expression of Dronc and Dcp-1 causes significantly m
C155-dependent UAS-Dcp-1 are the same data as are presented in (E), reprodu
(G and H) Quantification of degeneration severity as in Figures 2E and 2F. wt =
ank22001/ank22001 (n = 122 NMJs); dcp-1/+; ank2/ank2 = dcp-1Prev1/+; ank2200
ank22001/ank22001 (n = 127 NMJs). Mutant dcp-1 as either a heterozygote or a
degeneration events (p < 0.001). Error bars represent SEM. p valueswere determin
differences remain when comparisons are made using Student’s t test. n.s., noteration, we find that NMJ degeneration is moderately enhanced
by expression of dnJNK, perhaps consistent with a function for
JNK in axonal transport (Figure 8A). Next, we tested whether
a null mutation in the Drosophila homolog of NFkb (dorsal)
suppresses NMJ degeneration. We previously demonstrated
that the presynaptic nerve terminal in dorsal mutants is anatomi-
cally normal (Heckscher et al., 2007). Here, we show that the
dorsal mutation does not suppress NMJ degeneration in the
ank2 mutant (Figure 8B). These data rule out two prominent
downstream signaling systems linked to TNFR signaling, further
supporting the possibility that Wengen may signal primarily to
downstream caspases including Dcp-1.
Mitochondria are also integrally involved in proapoptotic
signaling pathways (Wang and Youle, 2009). However, a role
for mitochondria in developmental pruning and local degenera-
tion without cell death remains virtually unknown. In Drosophilaneuronal overexpression of Drice, Dredd, Dronc, or Dcp-1. wt = w1118 (n = 59
= 40 NMJs); elavC155-GAL4; UAS-Dronc (n = 50 NMJs); elavC155-UAS-Dcp-1
ore synaptic degeneration than in wild-type (p < 0.001). Note that data for
ced to highlight specific comparisons.
w1118 (n = 129 NMJs); dcp-1 = dcp-1Prev1/dcp-1Prev1 (n = 130 NMJs); ank2 =
1/ank22001 (n = 40 NMJs); dcp-1/dcp-1; ank2/ank2 = dcp-1Prev1/dcp-1Prev1;
homozygote significantly reduces the number of ank2-dependent synaptic
ed using one-way ANOVAwith post hoc Tukey-Kramer: ***p < 0.001. Statistical
significant.
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Figure 8. Mitochondria Are Required Locally for
Axonal and Synapse Degeneration
(A and B) Mutations in either the Drosophila JNK homolog
bsk or in the NFkb homolog dorsal do not suppress
synaptic degeneration caused by a disrupted spectrin/
ankyrin skeleton. dnJNK = elavC155-GAL4; dnbsk (n =
100 NMJs); a-spec = elavC155-GAL4; a-spec-RNAi (n =
57 NMJs); a-spec; dnJNK = elavC155-GAL4; a-spec-
RNAi/+; dnbsk/+ (n = 106 NMJs); dl = dl1/dl1 (n =
100 NMJs); ank2 = ank22001/ank22001 (n = 75 NMJs); dl1;
ank2 = dl1/dl1; ank22001/ank22001 (n = 77 NMJs).
(C) Mutations in miro suppress the synaptic degeneration
caused by neuronally expressed a-spectrin-RNAi (p <
0.001). miro = elavC155-GAL4; miro B682/miro B682 (n = 88
NMJs); a-spec = elavC155-GAL4; a-spectrin-RNAi (n = 58
NMJs); a-spec;miro = elavC155-GAL4; a-spectrin-RNAi/+;
miro B682/miro B682 (n = 209 NMJs).
(D) Representative images of third-instar muscle 6/7 NMJs
stained with the presynaptic active zone marker Brp
(green) and the postsynaptic marker Dlg (red). Neuronally
expressed a-spectrin RNAi causes neuronal degeneration
(top panel) and this is suppressed by the miro mutation
(bottom panel).
(E–H) Mutations in known components of mitochondrial-
dependent caspase signaling suppress ankyrin-dependent
synaptic degeneration. (E) Mutations in debcl suppress
ankyrin-dependent degeneration. debcl = debcl[E26]/
debcl[E26] (n = 60); ank2 = ank22001/ank22001 (n = 151);
decbl; ank = debcl[E26]/debcl[E26]; ank22001/ank22001(n =
103). (F) Representative images stained with presynaptic
Brp (green) andpostsynaptic Dlg (red).debclmutant animal
NMJs do not have any noticeable morphological abnor-
malities or synaptic degeneration (top panel); however,
there is a significant suppression of ankyrin-dependent
degeneration (bottom panel). (G) Mutations in dark sup-
press ankyrin2-dependent degeneration. dark = darkCD4/
dark CD4 (n = 80); ank2 = ank22001/ank22001 (n = 60); dark;
ank = darkCD4/dark CD4; ank22001/ank22001 (n = 160). (H)
Representative images stained with presynaptic Brp
(green) and postsynaptic Dlg (red). Animals mutant for dark
that produce NMJs do not have any noticeable morpho-
logical abnormalities or synaptic degeneration (top panel);
however, there is a significant suppression of ankyrin-
dependent degeneration (bottom panel). Degeneration
severity is measured as above.
Error bars represent SEM. p values were determined using
one-way ANOVA with post hoc Tukey-Kramer: *p < 0.05;
***p < 0.001. Statistical differences remain when compari-
sons are made using Student’s t test. n.s., not significant.
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mitochondria are necessary for the progression of prodegenera-
tive signaling in the periphery. In miro mutants the majority of
mitochondria remain stranded in the neuronal soma and soma-
proximal axon, whereas the distal axon and presynaptic nerve
terminal are largely devoid of this organelle. This was confirmed
by MitoTracker staining (Figure S10). Remarkably, the larval
nervous system is fully functional, and synaptic transmission770 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.remains robust in the miro mutant (Guo et al.,
2005; Russo et al., 2009).
First, we examined synapse morphology in
miro mutants and found no evidence of NMJdegeneration or altered neuromuscular growth (Figure S3). We
then examined miro mutations in animals also expressing
a presynaptic a-spectrin-RNAi construct that alone shows signif-
icant degeneration (Figures 8C and 8D). Remarkably, the pres-
ence of the miro mutation caused a dramatic suppression of
neuromuscular degeneration (Figures 8C and 8D). We confirmed
that mitochondria are diminished in axons of the a-spectrin-
RNAi; miro double mutant, just as in miro mutants alone
Figure 9. Summary and Model
(A) Summary of genetic data in support of prodegenerative-signaling pathways.
(1) The loss of either Eiger within peripheral glia or the loss of Wengen within
motoneurons suppresses ankyrin-dependent neuromuscular degeneration
(neuronal stress) at the DrosophilaNMJ. Based on these data, we propose that
Eiger and Wengen establish a glial-derived, prodegenerative-signaling system.
(2) Expression of either the initiator caspase Dronc or the effector caspase
Dcp-1 is sufficient to cause synaptic degeneration at the NMJ. Additionally,
Dcp-1 is necessary for prodegenerative signaling. Based on these data, we
propose the involvement of a caspase-signaling system that is activated
following disruption of the spectrin/ankyrin skeleton. (3) Mitochondria-depen-
dent signaling (mito) participates in the neurodegenerative-signaling system at
the Drosophila NMJ. A mutation in miro (not shown), which depletes mito-
chondria from motor axons and synapses, significantly suppresses degenera-
tion. Additionally, mutations in two genes, debcl and dark, previously shown to
function downstream of disrupted mitochondria in other systems, suppress
degeneration. Therefore, we propose the involvement of a mitochondria-
dependent signaling system in the degenerative response.
(B) Proposed model for glial-derived prodegenerative signaling in Drosophila
motoneurons. According to this model, a neuronal stress such as disruption of
the spectrin/ankyrin skeleton is detected by surrounding peripheral glia, which
respond by release of Eiger (TNF-a). Eiger is detected by Wengen (TNFR) in
motoneurons and may lead to downstream caspase activation followed by
disassembly of the motor axon and/or synapse. We also propose involvement
of a mitochondrial-dependent signaling system involving Debcl and Dark that
may function to potentiate the prodegenerative caspase response. Notably,
there may be direct signaling from a site of axonal stress to activation of
mitochondria-dependent degenerative signaling.
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the distal motoneuron axon and in the synapse, these data
suggest that that there could be a localized function for mito-
chondria in the axon and/or presynaptic nerve terminal that
participates in prodegenerative signaling.
It remains a formal possibility that the Miro molecule itself is
essential for prodegenerative signaling. To further investigate
the role of mitochondria-dependent signaling in axonal and
synapse degeneration, we examined mutations in two addi-
tional genes previously linked to mitochondrial-dependent
signaling that drives or potentiates caspase activity in other
systems (Wang and Youle, 2009). First, we demonstrate that
a loss-of-function mutation in the Drosophila death execu-
tioner Bcl-2 homolog, debcl (Sevrioukov et al., 2007) alone
does not cause NMJ degeneration or changes in NMJ
morphology (Figures 8E and 8F; Figure S3). However, when
debcl is placed in the ank2 mutant background, degeneration
is statistically significantly suppressed (Figures 8E and 8F). It
is well established that Debcl directly associates with mito-
chondria in Drosophila and other systems and promotes cas-
pase activity following mitochondrial disruption (Doumanis
et al., 2007). Next, we performed an identical analysis with
the Drosophila Apaf-1 (Apoptotic protease activating factor 1)
homolog termed Dark. Dark is known to act in a signaling
system downstream of mitochondrial disruption and is impor-
tant for the activation of the initiator caspase Dronc (reviewed
in Richardson and Kumar, 2002). Importantly, previous genetic
work has shown that dark interacts genetically with both dronc
and dcp-1 (Richardson and Kumar, 2002), the precise cas-
pases that we implicate in ank2-dependent NMJ degeneration
(see above). Here, we show that a loss-of-function dark muta-
tion has no effect on NMJ morphology (Figure S3), but dark
significantly suppresses ank2-dependent NMJ degeneration
(Figures 8G and 8H). When taken in context with previously
published genetic interactions, our data are consistent with
an emerging signaling system that couples disruption of mito-
chondria to Debcl, Dark, and downstream caspase activity. We
note that the suppression of NMJ degeneration by debcl and
dark is not as dramatic as suppression by dcp-1 mutations.
This is consistent with current models in which mitochon-
drial-dependent signaling, via these proteins, functions to
potentiate caspase activity that has been stimulated through
other events including proinflammatory cytokine signaling
(Richardson and Kumar, 2002; Wang and Youle, 2009). As
such, loss of these proteins may suppress amplification of
caspase activity but not block caspase activity. Finally, again
consistent, there is recently published evidence that disruption
of the spectrin/ankyrin/adducin skeleton causes a disruption of
mitochondria that resembles, phenotypically, mitochondrial
disruptions observed in diverse models of neurodegenerative
disease (Pielage et al., 2011; Menzies et al., 2002).
DISCUSSION
Here, we provide evidence for a prodegenerative-signaling
system that originates in motoneurons following a cellular stress,
passages through peripheral glial cells that are in close proximity
to the motoneuron axons, and ultimately includes the activationof an effector caspase in themotoneuron that drives local degen-
eration (Figure 9). These data also raise important questions. We
do not know how motoneuron stress is signaled to the sur-
rounding glia. One possibility is that this involves a factor
released from the motoneuron and detected by a receptor on
the glial cell. An alternative is that the glial cell could sense
a physical stress such as axonal swelling that has been shown
to accompany axonal blockages following disruption of axonal
transport and disruption of the spectrin/ankyrin skeleton
(Pilling et al., 2006; Shah et al., 2009). We have yet to deviseNeuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc. 771
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to provide formal evidence that loss of Dcp-1 is able to suppress
prodegenerative signaling from the Wengen receptor. However,
the near-complete suppression of neurodegeneration by the
loss of Dcp-1 and the observation that Dcp-1 is sufficient to
cause profound degeneration support the idea that Dcp-1 is
the final stage in the degenerative signaling cascade and likely
functions downstream of Wengen. Finally, we have yet to estab-
lish precisely where mitochondria-dependent signaling fits into
the prodegenerative cascade, and we discuss different possibil-
ities in greater detail below.
Glial Signaling in Motoneuron Degenerative Disease
Current models of neurodegenerative signaling in the neuromus-
cular system suggest that degeneration is initiated by cellular
stress in the motoneuron and that glial cells (microglia or astro-
cytes) participate in the progression of degenerative disease.
The participation of microglia and astrocytes occurs primarily
within the spinal cord, not within peripheral axons, and is thought
to contribute to the spread of degeneration throughout themoto-
neuron pool (Barbeito et al., 2004). Our data imply that peripheral
glia cells could be directly involved in the prodegenerative
pathway by secreting TNF-a. It may be reasonable to suspect
parallel signaling in mammalian systems. TNF-a is expressed
by Schwann cells, and TNF-a signaling from Schwann cells
has been implicated in proinflammatory disease including mul-
tiple sclerosis (Qin et al., 2008).
A role for TNF-a in motoneuron degenerative disease such as
ALS was largely discounted a number of years ago when it was
demonstrated that expression of mutant SOD1 in motoneurons
of TNF-a knockout mice resulted in motoneuron degeneration
that was no different than that observed in a wild-type back-
ground (Gowing et al., 2006). However, several issues are worth
considering. First, SOD1 transgenes were highly expressed, far
beyond that that is observed in disease, and this may have over-
come any protective effect provided by the absence of TNF-a.
Second, even in Drosophila, loss of TNF-a provides a modest
protective effect compared to loss of the effector caspase
Dcp-1. Third, it was demonstrated that two other TNF-a-like
cytokines are upregulated in the TNF-a knockout mouse, indi-
cating a possible compensatory process. It might be reasonable,
given the many examples of compensatory regulation within
signaling systems of knockout mice, to suspect that the upregu-
lated cytokines replaced TNF-a signaling functions during prode-
generative signaling in these experiments.
What might be the logic for incorporating a glial cell in the
induction of prodegenerative signaling? A likely explanation is
that by partitioning the prodegenerative-signaling system
between two cells, additional layers of control can be imposed
on the system so that errant activation of degeneration is
unlikely. For example TNF-a activating enzyme (TACE) is
required to cleave TNF-a prior to secretion and represents an
essential form of regulation that may be required in glia. In addi-
tion full activation of the degenerative response might include
active insertion of the TNFR in the membrane by the moto-
neuron. This organization would restrict the spread of prodege-
nerative signaling such that only motoneurons that have been
stressed and have actively inserted TNFR in the membrane will772 Neuron 72, 760–775, December 8, 2011 ª2011 Elsevier Inc.respond to TNF-a released from the glial cell and degenerate.
This possibility remains to be tested.
Localization and Control of Prodegenerative Signaling
Here, we demonstrate that peripheral glial cells that surround
motor axons express Eiger. Because Eiger knockdown in these
cells is sufficient to suppress degeneration after an axonal insult,
we conclude that Eiger has the potential to activate prodegener-
ative signaling via the Wengen receptor along the length of the
motor axons, as diagrammed in Figure 9. However, it remains
unknown how this prodegenerative signaling spreads to drive
the degeneration of the presynaptic nerve terminal at the NMJ
because glial ensheathment of motor axons stops prior to the
NMJ (Figure 1). One possibility is that dynamic invasion of the
NMJ by peripheral glia conveys prodegenerative signaling to
this site (Fuentes-Medel et al., 2009). Another possibility is that
caspases, once activated in the axon, can be mobilized to the
presynaptic terminal of the NMJ. This possibility is consistent
with the catalytic activity of caspases and our demonstration
of caspase mobility within motor axons (Figure 7C). Ultimately,
the mechanisms that disseminate prodegenerative signaling
throughout a cell are not well understood. Likewise, it is not
understood how prodegenerative signaling responsible for
selective dendrite pruning is restricted to specific neuronal
compartments. Finally, it is worth emphasizing that many of
the prodegenerative-signaling molecules identified in our study
do not adversely effect neuromuscular development when
mutated or deleted. For example mutations in eiger, dcp-1,
debcl, and dark show no obvious NMJ phenotype in larval stages
and are homozygous viable as adult flies. Thus, the neuroprotec-
tive effects of these loss-of-function mutations can be separated
from the molecular mechanisms of motoneuron growth control.
As such, these proteins could be considered good potential
targets for therapeutic intervention aimed at slowing the pro-
gression of neuromuscular degeneration.
Mitochondrial Signaling during Neurodegenerative
Disease
Our data provide evidence that mitochondria are required in the
local axon and synaptic environments during prodegenerative
signaling. In addition we recently established that mitochondria
are disrupted, visualized ultrastructurally, in nerve terminals
undergoing degeneration (Pielage et al., 2011), consistent with
findings in mammalian systems and human disease (Menzies
et al., 2002; Martin et al., 2007). In our experiments, the miro
mutation causes depletion of mitochondria from the axon and
nerve terminal, stranding them primarily in the motoneuron
soma and proximal axons. Yet, in the miro mutant background,
a-spectrin-dependent degeneration is suppressed. This finding
is in apparent contrast to the well-established function for mito-
chondria in the cell body during proapoptotic cell death sig-
naling cascades (reviewed in Wang and Youle, 2009). Although
proapoptotic signaling from mitochondria is strongly implicated
in neurodegenerative disease, our data suggest that mitochon-
dria might represent a means to restrict or locally modulate
prodegenerative signaling within specific neuronal compart-
ments, based on data from the miro mutant background
(Figure 8D).
Neuron
Glial-Derived Prodegenerative SignalingIn Drosophila, the Bcl-2 homolog Debcl functions to promote
mitochondrial cytochrome c release that, in turn, modulates
Dark-dependent activation of the initiator caspase Dronc
(Richardson and Kumar, 2002). Active Dronc mediates the acti-
vation of effector caspases including Dcp-1. By demonstrating
that mutations in both debcl and dark suppress neurodegenera-
tion, we provide evidence that signaling downstream of mito-
chondria interfaces with the degenerative signaling pathway,
potentially serving to amplify caspase activity. This is consistent
with previously published data showing that mutations of two
other proapoptotic Bcl-2 family proteins in a mouse model of
familial ALS not only halt neuronal loss but also prevent axonal
degeneration and paralysis (Reyes et al., 2010).
EXPERIMENTAL PROCEDURES
Fly Stocks
Flies were maintained at 25C on normal food, unless otherwise noted. The
following strains were used in this study: w1118 (wild-type); egrD25 (generation
of mutants described below); elavC155-GAL4 (neuron-specific; Lin and
Goodman, [1994]); OK371-GAL4 (motoneuron-specific; Bloomington Stock
Center, Bloomington, IN, USA); eveRRa-GAL4 (courtesy of R. Baines, Univer-
sity of Manchester); egr-GAL4 (courtesy of Heberlein Lab, UCSF; position of
insertion was verified by standard reverse PCR); repo-GAL4 (Bloomington
Stock Center); ank22001 (Pielage et al., 2008); dcp-1Prev1 (courtesy of K.
McCall, Boston University; Laundrie et al., [2003]); pUAS-Dcp-1, pUAS-Drice,
pUAS-Dredd, pUAS-Dronc (courtesy of O. Yoo, Korea Advanced Institute of
Science and Technology); pUAS-wengen-RNAi (courtesy of M. Miura, RIKEN
Brain Science Institute); UAS-DNbsk (Weber et al., 2000); UAS-a-spectrin-
RNAi (line 110417; Vienna Drosophila RNAi Center); miroB682 (courtesy of
K.E. Zinsmailer, University of Arizona); UAS-CD8-GFP, UAS-nuclear-localiza-
tion-signal-GFP, pUAS-egr-RNAi (courtesy of M. Miura); pUAS-Dronc-FLAG
(courtesy of S. Kornbluth); darkCD4 (courtesy of J.M. Abrams); debcl [E26]
(Bloomington Stock Center); and dl1 (Bloomington Stock Center).
Generation of Wgn-Venus and Dcp-1-Venus Flies
The full-length Wengen cDNA RE29502 and the full-length Dcp-1 cDNA
LD13945 were obtained from the Drosophila Genomics Research Center
(Indiana University, Bloomington, IN, USA) and tagged with a C-terminal fusion
protein encoding the fluorescent protein Venus by cloning into the plasmid
PtWV using the Gateway System (Carnegie Drosophila Gateway Collection).
Transgenic flies were produced and balanced using standard procedures
(BestGene).
Generation of eiger Null Mutants
Excision lines of eigerwere generated by the excision of the transposon inser-
tion line egr-GAL4 using the delta[2-3] transposase. PCR screening with
homozygous progeny was performed with primers 50- gcaggcgcccttaagtatg-
30 and 50- gcttgatcagccaagaaacc-30. Sequencing of PCR products revealed
that 1.5 kb of the genomic region was deleted in egrD25.
Immunohistochemistry
Wandering third-instar larvae were dissected and stained according to stan-
dard procedures (Massaro et al., 2009). Primary antibodies were used at the
following dilutions: 1:100 anti-Bruchpilot (Developmental Studies Hybridoma
Bank); 1:20 anti-Futsch (22C10; Developmental Studies Hybridoma Bank);
1:10,000 anti-Dlg (anti-Discs large); 1:500 anti-Eiger (courtesy of M. Miura);
1:400 anti-GFP (3E6; Invitrogen); and 1:20 anti-Repo (BD12; Developmental
Studies Hybridoma Bank). Secondary Alexa Fluor antibodies (goat anti-mouse
488, goat anti-rabbit 555, and goat anti-rabbit 647) were obtained from Invitro-
gen and diluted in PBT to a final concentration of 1:500. All other secondary
antibodies and Cy3- and Cy5-conjugated HRP were obtained from Jackson
ImmunoResearch Laboratories, Inc., or Invitrogen and used at a 1:300
dilution.Imaging and Analysis
Images were digitally captured using a CoolSNAPHQ CCD camera mounted
on a Zeiss Axiovert 200Mmicroscope and analyzed using SlideBook software
(Intelligent Imaging Innovations). Individual nerves and synapses were opti-
cally sectioned at 0.5 mm using a piezoelectric-driven z-drive controlling
the position of a Zeiss Plan-Apochromat 1003 oil immersion objective
(NA = 1.4). Images were deconvolved with the nearest neighbor algorithm,
and Z stacks were combined into a single projection image. For quantification
of Brp fluorescence within nerves, the maximum fluorescence intensity of
each Brp punctum within a nerve area was determined for each 2D projection
image using a semiautomated procedure as described previously (Massaro
et al., 2009; Heckscher et al., 2007). Image stacks were taken at the same
exposure from animals projected into a single 3D stack before masking. No
alterations were made to the images before quantification.
NMJ Degeneration Quantification
Degeneration was scored at 403 magnification with the observer being blind
to the genotype. Segments A2–A6 were counted, and a degenerative event
was defined as an area of the NMJ with clearly defined postsynaptic Dlg
staining without any apposing presynaptic Brp staining.
EM
Wild-type third-instar larvae were prepared for EM as described (Pielage et al.,
2011).
Electrophysiology
Recordings were made in HL3 saline (Ca2+ 0.4 mM, Mg2+ 10 mM) frommuscle
6 in abdominal segment 3 of third-instar larvae as previously described
(Massaro et al., 2009). Measurements of EPSP and spontaneous miniature
release event amplitudes were made using semiautomated routines in Mini
Analysis software (Synapsoft). Recordings were accepted for measurement
with resting potentials more hyperpolarized than 60 mV and with input resis-
tances greater than 5 MU.
FRAP
FRAP experiments were performed within single axons projecting to muscle 4
(segments A2 and A3) of wandering third-instar larvae. See Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes ten figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2011.09.031.
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